Rescue Surgery in a Patient With Metastatic Melanoma and BRAF V600E Mutation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cirugía Española (English Edition)

• Publication date

  2018-07-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CIRENG.2018.11.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted agents and immunotherapies: optimizing outcomes in melanoma

  2017cited by this paper
• Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.

  2017cited by this paper
• The rapidly evolving therapies for advanced melanoma--Towards immunotherapy, molecular targeted therapy, and beyond.

  2016cited by this paper
• Improved overall survival in melanoma with combined dabrafenib and trametinib.

  2015cited by this paper
• Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

  2014cited by this paper
• The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic Melanoma.

  2013cited by this paper
• Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.

  2012cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

  2003cited by this paper
• Surgical treatment of metastatic melanoma of the small bowel.

  1996cited by this paper

• No citing papers are available for this paper.